© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
July 06, 2020
Pacific Research Institute’s Winegarden Sees Dose of Competition as Way to Lower OOP Costs
July 02, 2020
Cardinal Health recently conducted a survey of more than 100 rheumatologists asking their feelings about biosimilars, and the findings revealed that the majority of them were familiar with and comfortable prescribing biosimilars.
June 04, 2020
Proving therapeutic equivalence is a major hurdle.
Developing a biosimilar can be more challenging than developing the innovator product because of the need to match the attributes of a highly complex molecules.
May 18, 2020
The purpose of biosimilar is simple: reduce healthcare costs, pure and simple. Here are 11 trends affecting biosimilars over the last year in the U.S.
Just as we’ve seen the entire healthcare landscape change in 2020 because of COVID-19, the world of biosimilars is ever-changing.
May 04, 2020
January 02, 2020
Several biosimilars will come to market within the next few years.
Study finds that biologics that faced competition from biosimilars showed reductions in net prices and leveling off of list price increases.
May 01, 2019
The FDA Commissioner says that insurers can help biosimilar adoption by taking short-term financial losses over long-term drug savings. What else should they be doing?